Brief: Brainchip Holdings Evaluates Redomiciling To US
27/02/2025 07:08
Feb 27 (Reuters) - Brainchip Holdings Ltd BRN.AX: BRAINCHIP EVALUATES REDOMICILING TO US BRAINCHIP EVALUATES REDOMICILING TO US IN 2025 DECISION TO INVESTIGATE REDOMICILING WAS REACHED AFTER BOARD CONDUCTED AN EXTENSIVE STRATEGIC REVIEW OF COMPANY BOARD DETERMINED THAT A SOLE US LISTING WAS IN BEST INTERESTS OF BRAINCHIP SHAREHOLDERS WOULD SEEK TO SIMULTANEOUSLY DELIST SECURITIES FROM QUOTATION ON AUSTRALIAN SECURITIES EXCHANGE Further company coverage: BRN.AX ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Brainchip Holdings
See all newsAustralia's NEXTDC, Macquarie Technology slump to multi-year lows on AI financing fears
Brief: Brainchip Launches Symphony Community Akida Bundle For IBM’S Workload Management Solution
Australia's BrainChip jumps on distribution deal with South Korea's ASICLAND
Brief: Brainchip Holdings Announces IP License Agreement With ASICLAND
Brief: Brainchip Holdings Announces Akida 2 Licensing Agreement With Edgeai